Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Snoeck

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Antiviral Research|July 13, 2006
Papillomavirus and treatmentRobert Snoeck
Trends in Pharmacological Sciences|September 6, 2023
Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine developmentGraciela Andrei, Robert Snoeck
Molecules (Basel, Switzerland)|March 6, 2021
Advances and Perspectives in the Management of Varicella-Zoster Virus InfectionsGraciela Andrei, Robert Snoeck
Current Opinion in Infectious Diseases|November 3, 2015
Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapyGraciela Andrei, Robert Snoeck
Expert Opinion on Pharmacotherapy|May 26, 2009
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesionsGeorges Coremans, Robert Snoeck
Viruses|October 14, 2011
Cidofovir Activity against Poxvirus InfectionsGraciela Andrei, Robert Snoeck
Expert Opinion on Emerging Drugs|June 25, 2011
Emerging drugs for varicella-zoster virus infectionsGraciela Andrei, Robert Snoeck
Current Opinion in Infectious Diseases|October 25, 2013
Herpes simplex virus drug-resistance: new mutations and insightsGraciela Andrei, Robert Snoeck
Current Opinion in Investigational Drugs (London, England : 2000)|December 13, 2002
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patientsRobert Snoeck, Eric De Clercq
Current Opinion in Infectious Diseases|April 20, 2002
New treatments for genital herpesRobert Snoeck, Erik De Clercq
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Antiviral Research|July 13, 2006
Papillomavirus and treatmentRobert Snoeck
Trends in Pharmacological Sciences|September 6, 2023
Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine developmentGraciela Andrei, Robert Snoeck
Molecules (Basel, Switzerland)|March 6, 2021
Advances and Perspectives in the Management of Varicella-Zoster Virus InfectionsGraciela Andrei, Robert Snoeck
Current Opinion in Infectious Diseases|November 3, 2015
Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapyGraciela Andrei, Robert Snoeck
Expert Opinion on Pharmacotherapy|May 26, 2009
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesionsGeorges Coremans, Robert Snoeck
Viruses|October 14, 2011
Cidofovir Activity against Poxvirus InfectionsGraciela Andrei, Robert Snoeck
Expert Opinion on Emerging Drugs|June 25, 2011
Emerging drugs for varicella-zoster virus infectionsGraciela Andrei, Robert Snoeck
Current Opinion in Infectious Diseases|October 25, 2013
Herpes simplex virus drug-resistance: new mutations and insightsGraciela Andrei, Robert Snoeck
Current Opinion in Investigational Drugs (London, England : 2000)|December 13, 2002
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patientsRobert Snoeck, Eric De Clercq
Current Opinion in Infectious Diseases|April 20, 2002
New treatments for genital herpesRobert Snoeck, Erik De Clercq
Pageof 26